Your session is about to expire
← Back to Search
GLP-1 Therapy for Diabetes
Study Summary
This trial will investigate if a hormone called GLP-1, which is used to treat obesity and diabetes, also causes the body to secrete a protein that could help treat diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 104 Patients • NCT04189848Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
In what ways is Cyanocobalamin employed medically?
"Cyanocobalamin is a successful treatment for vitamin deficiency, diabetic neuralgia and can be used to introduce therapeutic doses of vitamins."
Is Cyanocobalamin a safe health supplement for human consumption?
"The safety of Cyanocobalamin has been rigorously evaluated in a Phase 4 trial and is thus assigned a score of 3."
What aims are being sought with this medical experiment?
"This clinical trial will gauge the efficacy of various interventions over a span of 6 weeks, primarily by measuring Uncoupling protein 1 (UCP1) levels in adipose tissue. Other metrics used to evaluate outcomes include Interleukin-11 as a cytokine marker, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), and Suppressor Of Cytokine Signaling 3 band intensity/Western blot from peripheral blood mononuclear cells."
Could I potentially qualify for participation in this medical trial?
"Prospective participants of this medical trial must possess glucose intolerance and should fall between the ages 18 to 50. This clinical trial is currently in need of about 26 people for enrolment."
Is the age eligibility for this clinical trial restricted to those over 25 years?
"Based on the parameters set forth in the eligibility criteria, potential patients must be between 18 and 50 years of age to participate."
Has Cyanocobalamin been investigated in other scientific experiments?
"Currently, 14 separate clinical trials are running to investigate Cyanocobalamin. Of those studies, 4 have advanced into Phase 3 of the trial process. Trials for this medication can be found in 888 different sites across Ōtake, Tokyo."
What is the cap on participants in this experiment?
"Affirmative, the information on clinicaltrials.gov reveals that this trial is currently enrolling patients. The study was initially uploaded to the database on May 15th 2020 and last modified on September 30th 2022 with a goal of recruiting 26 participants from one research centre."
Is this experiment in need of additional participants?
"Affirmative. According to the information posted on clinicaltrials.gov, this research is currently in search of test subjects. The study was launched May 15th 2020 and saw its latest alteration September 30th 2022. 26 patients must be enrolled from a single trial site for completion purposes."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- The University of Texas Health Science Center at Houston: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger